|Description||Suppression of Tumorigenicity 2 (ST2), a member of the Interleukin-1 receptor family, has two isoforms, one is soluble form (sST2) and the other one is transmembrane form (ST2L). sST2, lacking the transmembrane and intracellular domains, can prevent the interaction between IL-33 and ST2L. It plays a role in inflammatory and immune processes and is considered as a promising marker for myocardial stress.|
|Purification||Protein A/G affinity column|
|Production||Cultured in vitro under conditions free from animal-derived components|
|Recommended pairs||Sandwich immunoassay (Capture-Detection):
6B3 - 8H6
6B3 - 16G5
|Formulation||1) PBS, pH 7.4, containing 0.03% Proclin 300
2) 50 mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% Proclin 300 *
*: For new batch since 09/01/2018, please refer to COA.
|Storage||For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles.|
|Note||GenScript can customize this product per customer's request including product size, buffer components, etc.|
For more documents, please visit "Technical Support".